| scholarly article | Q13442814 |
| P50 | author | Yogesh B Patil | Q59200388 |
| P2093 | author name string | Jayanth Panyam | |
| Linan Ma | |||
| Ayman Khdair | |||
| Udaya S Toti | |||
| P2860 | cites work | Drug delivery systems: entering the mainstream | Q29618136 |
| A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 1. Synthesis and characterization | Q33223638 | ||
| Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery | Q33270241 | ||
| Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer | Q33303505 | ||
| Ligand-targeted therapeutics in anticancer therapy | Q34152775 | ||
| Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer | Q34426754 | ||
| Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo | Q34597483 | ||
| Biodegradable nanoparticles for drug and gene delivery to cells and tissue | Q35082117 | ||
| PEGylated nanoparticles for biological and pharmaceutical applications | Q35082131 | ||
| The dawning era of polymer therapeutics | Q35128900 | ||
| Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential. | Q35749889 | ||
| Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. | Q36497423 | ||
| Micellar nanocarriers: pharmaceutical perspectives | Q36655007 | ||
| Nanotechnology for targeted cancer therapy | Q36842770 | ||
| Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells | Q38334788 | ||
| Overcoming the formulation obstacles towards targeted chemotherapy: in vitro and in vivo evaluation of cytotoxic drug loaded immunonanoparticles | Q40002076 | ||
| Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery | Q40188447 | ||
| A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers | Q40244491 | ||
| Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. | Q40277654 | ||
| Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles | Q40327793 | ||
| Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments | Q40371100 | ||
| Super pH-sensitive multifunctional polymeric micelle | Q40442115 | ||
| Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. | Q40447478 | ||
| Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer | Q40518381 | ||
| Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery | Q40713744 | ||
| "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers | Q42544966 | ||
| Synthesis and characterisation of a degradable poly(lactic acid)-poly(ethylene glycol) copolymer with biotinylated end groups. | Q43827541 | ||
| Folate receptor targeted biodegradable polymeric doxorubicin micelles | Q44175603 | ||
| Rational design of an active avidin monomer. | Q44233703 | ||
| Surface-engineered nanoparticles for multiple ligand coupling | Q44551941 | ||
| Biotin accounts for only half of the total avidin-binding substances in human serum. | Q51589752 | ||
| Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genome stability in cultured human lymphocytes. | Q51726282 | ||
| An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel | Q73311203 | ||
| Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles | Q73825954 | ||
| Drug delivery and targeting | Q74525964 | ||
| Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody | Q80351088 | ||
| Cystatin incorporated in poly(lactide-co-glycolide) nanoparticles: development and fundamental studies on preservation of its activity | Q80362555 | ||
| P433 | issue | 5 | |
| P921 | main subject | nanoparticle | Q61231 |
| drug delivery | Q1392806 | ||
| P304 | page(s) | 859-866 | |
| P577 | publication date | 2008-11-18 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery | |
| P478 | volume | 30 |
| Q37389368 | "Clickable" polymer nanoparticles: a modular scaffold for surface functionalization. |
| Q38754657 | A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules |
| Q39669032 | Active targeting behaviors of biotinylated pluronic/poly(lactic acid) nanoparticles in vitro through three-step biotin-avidin interaction |
| Q92446404 | Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1α |
| Q36839361 | Application of the central composite design to optimize the preparation of novel micelles of harmine |
| Q40950343 | Biocatalyzed approach for the surface functionalization of poly(L-lactic acid) films using hydrolytic enzymes |
| Q39582857 | Biodegradable Three-Layered Micelles and Injectable Hydrogels |
| Q39096259 | Biorthogonal click chemistry on poly(lactic-co-glycolic acid)-polymeric particles |
| Q34447986 | Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. |
| Q39632550 | Characterization of nano oxaliplatin prepared by novel Fat Employing Supercritical Nano System, the FESNS® |
| Q34620051 | Construction and application of biotin-poloxamer conjugate micelles for chemotherapeutics |
| Q91871531 | Current trends and challenges in cancer management and therapy using designer nanomaterials |
| Q51101005 | Design of block-copolymer-based micelles for active and passive targeting. |
| Q38067265 | Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. |
| Q64072752 | Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis |
| Q37314147 | Effects of amphiphilic diblock copolymer on drug nanoparticle formation and stability. |
| Q39527615 | Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles |
| Q39064707 | Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification |
| Q37607750 | Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells |
| Q26828930 | Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities |
| Q49711598 | Fabrication of Bioactive Surfaces by Functionalization of Electroactive and Surface-Active Block Copolymers |
| Q37714195 | Flash nanoprecipitation: prediction and enhancement of particle stability via drug structure. |
| Q39629193 | Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery |
| Q39336419 | Folic acid functionalized nanoparticles for enhanced oral drug delivery |
| Q38095361 | Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance. |
| Q53631271 | Hydrophilic block azidation of PCL-b-PEO block copolymers from epichlorohydrin. |
| Q33549485 | Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel |
| Q42362653 | In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin |
| Q88013425 | Insulin adsorption on functionalized silica surfaces: an accelerated molecular dynamics study |
| Q34036920 | Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery |
| Q38813182 | Lipid-based nanovesicles for nanomedicine. |
| Q37955127 | Microfabricated particulate drug-delivery systems |
| Q38383487 | Multifunctional nanomedicines: potentials and prospects |
| Q47261880 | Multivalent Presentation of Peptide Targeting Groups Alters Polymer Biodistribution to Target Tissues |
| Q92733299 | Nanodrug Delivery Systems for the Treatment of Ovarian Cancer |
| Q38234908 | Nanodrug delivery in reversing multidrug resistance in cancer cells |
| Q35553193 | Nanoparticle PEGylation for imaging and therapy |
| Q64116692 | Nanostructured carriers as innovative tools for cancer diagnosis and therapy |
| Q59049899 | Nanotechnology in Cancer Drug Delivery and Selective Targeting |
| Q38228137 | Natural and synthetic poly(malic acid)-based derivates: a family of versatile biopolymers for the design of drug nanocarriers |
| Q28476756 | Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro |
| Q39095290 | Novel functionalization strategies to improve drug delivery from polymers. |
| Q47754415 | Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis. |
| Q37250009 | Paclitaxel Nano-Delivery Systems: A Comprehensive Review |
| Q92860814 | Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer |
| Q49643751 | Polymeric micelles as cutaneous drug delivery system in normal skin and dermatological disorders |
| Q47621457 | Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy |
| Q51291038 | Preclinical efficacy and safety assessment of nano-oxaliplatin oral formulation prepared by novel Fat Employing Supercritical Nano System, the FESNS®. |
| Q59113808 | Preparation and Characterization of Paclitaxel Loaded SF/PLLA-PEG-PLLA Nanoparticles via Solution-Enhanced Dispersion by Supercritical CO2 |
| Q52584038 | Preparation of a novel lipid-core micelle using a low-energy emulsification method. |
| Q39298620 | Protein-polymer hybrid nanoparticles for drug delivery |
| Q64897522 | Recent Advances in Degradable Hybrids of Biomolecules and NGs for Targeted Delivery. |
| Q58735813 | Recent advances in "smart" delivery systems for extended drug release in cancer therapy |
| Q35917427 | Reformulating Tylocrebrine in Epidermal Growth Factor Receptor Targeted Polymeric Nanoparticles Improves Its Therapeutic Index |
| Q57365642 | Self-assembly of a biodegradable branched PE-PCL-b-PEC amphiphilic polymer: synthesis, characterization and targeted delivery of doxorubicin to cancer cells |
| Q38440419 | Simulating the co-encapsulation of drugs in a "smart" core-shell-shell polymer nanoparticle |
| Q30430620 | Stereocomplexed poly(lactic acid)-poly(ethylene glycol) nanoparticles with dual-emissive boron dyes for tumor accumulation |
| Q50472956 | Structure of drug delivery DPPA and DPPC liposomes with ligands and their permeability through cells. |
| Q91941856 | Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against re |
| Q38899902 | Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges. |
| Q36307546 | Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics |
| Q51392678 | Synthesis of cholic-acid-carrying polymer and in-vitro evaluation of hepatoma-targeting nanoparticles decorated with the polymer. |
| Q39630195 | Target-Specific Cellular Uptake of Taxol-Loaded Heparin-PEG-Folate Nanoparticles |
| Q37850785 | Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles |
| Q36934007 | Targeted polymeric therapeutic nanoparticles: design, development and clinical translation |
| Q37438909 | The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. |
Search more.